GondolaBio Email Formats

Biotechnology Research • Palo Alto, California, United States • 51-100 Employees

GondolaBio Email Formats

GondolaBio uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@gondolabio.com), used 76.1% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@gondolabio.com	76.1%
{first initial}.{last name}	j.doe@gondolabio.com	17.4%
{2char}	{2char}@gondolabio.com	6.5%

Key Contacts at GondolaBio

Gyanendra Kumar

Director, Computational Chemistry & Structural Biology

Raheel Ata

Executive Director Of Business Development & Operations

Jiachen Chu

Associate Director Bd & Ops

Jeff Chen

Sr. Director, Business Development & Operations

Rishi Bagrodia

Executive Director, Bd Strategy & Operations

Cybele Gouverneur

Director, Global Patient Advocacy, Portal

Charles Ge

Executive Director, Bd & Ops

Mollie Chipman

Associate Director Of Business Development And Operations

Nile Abularrage

Associate Director, Business Development & Operations

Weibin Zha

Director Of Dmpk

Company overview

Headquarters	3160 Porter Dr, Palo Alto, California 94304, US
Website	gondolabio.com
NAICS	541714
Employees	51-100
Socials

About GondolaBio

GondolaBio is a clinical-stage biopharmaceutical company focused on developing next-generation therapeutics for genetic diseases. Originally launched as BridgeBioX, a subsidiary of BridgeBio, GondolaBio secured $300M in private financing from external investors in 2024 and became an independent company within the BridgeBio ecosystem. The company aims to leverage cutting-edge biological research to create breakthrough medicines addressing high unmet needs across multiple therapeutic areas, including neurology, pulmonology, cardiology, nephrology, and endocrinology. Located on the Stanford Life Sciences campus, GondolaBio fosters a unique hybrid environment where top scientists from around the world collaborate with senior leadership and advisors, blending industry expertise with academic innovation.